In view of the fact that GPC1 is more abundantly expressed in the brain, we focused our study on GPC1 and demonstrated that the proliferation of U118 glioma cells was promoted by GPC1 overexpression but weakened by GPC1 deletion. This evidence concerns the gene GPC1 and central nervous system cancer.